Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA(TM) (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit GlobeNewswire January 30, 2026 TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed for bedtime dosing bypasses first-pass metabolism, optimizing parent-drug exposure during sleep […]

With Halborn Audit and V1 Protocol Activated Mutuum Finance (MUTM) Raises Over $20M Since Q1 2025 GlobeNewswire January 30, 2026 DUBAI, United Arab Emirates, Jan. 30, 2026 (GLOBE NEWSWIRE) — The start of 2026 has brought a major shift to the decentralized finance world. A new project called Mutuum Finance has reached a massive goal.

OTC Markets Group Welcomes AltaGas Ltd. to OTCQX GlobeNewswire January 30, 2026 NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced AltaGas Ltd. (TSX: ALA; OTCQX: ATGFF), a leading North American infrastructure company, has qualified to trade

OTC Markets Group Welcomes Emerita Resources Corp. to OTCQX GlobeNewswire January 30, 2026 NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF), a natural resource company, has qualified to trade

Press Release: Sanofi's Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease GlobeNewswire January 30, 2026 Sanofi's Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy results from several clinical studies and real-world evidence If approved, Rezurock would offer a new

KRAKacquisition Corp Announces Closing of Upsized $345 Million Initial Public Offering and Full Exercise of Over-Allotment Option GlobeNewswire January 30, 2026 Cheyenne, WY, USA, Jan. 30, 2026 (GLOBE NEWSWIRE) — KRAKacquisition Corp (the “Company”), a special purpose acquisition company sponsored by an affiliate of Natural Capital, Tribe Capital, and Payward, Inc. (“Kraken“), today announced the

Immunocore announces R&D leadership evolution GlobeNewswire January 30, 2026 Immunocore announces R&D leadership evolution Dr. David Berman will depart the Company Dr. Mohammed Dar, Chief Medical Officer, and Mark Moyer, Head of Regulatory Sciences, promoted to Executive Vice President roles (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 30 January 2026) Immunocore Holdings plc

VEON Partners with MindBridge to Enhance Financial Analytics, Audit and Internal Controls with Augmented Intelligence Capabilities GlobeNewswire January 30, 2026 Dubai and Ottawa, January 30, 2026: VEON Ltd. (NASDAQ: VEON), a global digital operator, and MindBridge, the leader in AI-powered financial intelligence, today announced a strategic collaboration to deploy artificial intelligence-powered analytics tools across VEON's

BitMart Launches “Principal-Protected Copy Trading,” Introducing a Master-Compensated Risk Model GlobeNewswire January 30, 2026 Mahe, Seychelles, Jan. 30, 2026 (GLOBE NEWSWIRE) — BitMart, the premium global digital asset trading platform, announced the official launch of its innovative product–“Principal-Protected Copy Trading.” This model introduces a collateral-backed mechanism where Masters (lead traders) guarantee to compensate Followers for

VenHub Begins Trading on Nasdaq Under Ticker Symbol “VHUB” Reimagining Retail to Address a Multi-Trillion-Dollar Market Opportunity with Fully Autonomous Smart Stores GlobeNewswire January 30, 2026 LAS VEGAS, Jan. 30, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced that it